We understand that people with cancer are worried about coronavirus. Here is the latest guidance. We will update it regularly.

Publication Details

Need to talk? Call us free*
0800 808 00 00 Monday to Friday, 9am-8pm
Azacitidine for acute myeloid leukaemia (AML). A guide for patients

Azacitidine for acute myeloid leukaemia (AML). A guide for patients (June 2019)

Azacitidine is a chemotherapy drug used for the treatment of adult patients with acute myeloid leukaemia, high risk myelodysplastic syndrome or chronic myelomonocytic leukaemia who are not eligible for stem cell transplant. This booklet is for patients, family or friends of the patient, or a carer who like to know more about this drug. It describes what azacitidine is, how it is given, and the possible side-effects. It also has details of useful information and support.

Author(s)
Leukaemia Care
Place of publication
Worcester
Publisher
Date of publication
June 2019
Pages
16pp
Price
Free.
Format
Booklet
Language
English
Flesch readability score
55.8
Download this resource
Need to talk? Call us free*
0800 808 00 00 Monday to Friday, 9am-8pm